Autism and mitochondrial disease

Developmental Disabilities Research Reviews

Volumn 16, Issue 2, 2010, Pages 144-153

  Haas, Richard H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Autism spectrum disorder; Copy number variation; Genetics; Immune modulators; Mitochondria; Mitochondrial disease

Indexed keywords

INTERLEUKIN 10; LACTIC ACID; MITOCHONDRIAL DNA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTISM; CHEMICAL ANALYSIS; COMPULSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNIZATION; IMMUNOMODULATION; INCIDENCE; LANGUAGE DEVELOPMENT; MULTIPLE ORGAN FAILURE; NERVE DEGENERATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIALIZATION;

EID: 77956249894     PISSN: 19405510     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/ddrr.112     Document Type: Review

References (90)

1. Abrahams BS, Geschwind DH. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341-55.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, text revision (DSM-IVTR), 4th ed. Washington, DC: American Psychiatric Publishing.
3. Amiot A, et al. 2009. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology. 137: 101-109.
4. Ashwood P, et al. 2004. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 24:664-673. (Pubitemid 40933118)
5. Ashwood P, et al. 2006. The immune response in autism: a new frontier for autism research. J Leukoc Biol 80:1-15.
6. Atkuri KR, et al. 2009. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci USA 106:3941-3945.
7. Babatz TD, et al. 2009. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res 2:359-364.
8. Barshop BA. 2004. Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion 4:521-527.
9. Bellizzi D, et al. 2006. Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells 11:883-891. (Pubitemid 44084024)
10. Bernier FP, et al. 2002. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406-1411.
11. Blomquist HK, et al. 1985. Frequency of the fragile X syndrome in infantile autism. A Swedish multicenter study. Clin Genet 27:113-117.
12. Buie T, et al. 2010a. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125 (Suppl 1):S1-S18.
13. Buie T, et al. 2010b. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics 125 (Suppl 1):S19-S29.
14. Camilleri M, et al. 2009. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 296:G510-G516.
15. Centers for Disease Control and Prevention (CDC). 2009. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 58:20.
16. Chitkara DK, et al. 2003. Abnormalities in gastro-intestinal motility are associated with diseases of oxidative phosphorylation in children. Am J Gastroenterol 98:871-877.
17. Chugani DC, et al. 1999. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 23: 635-641.
18. Coleman M, Blass JP. 1985. Autism and lactic acidosis. J Autism Dev Disord 15:1-8.
19. Courchesne E, et al. 1994. Cerebellar hypoplasia and hyperplasia in infantile autism. Lancet. 343:63-64.
20. Croonenberghs J, et al. 2002. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med. 32:1457-1463.
21. DeStefano F, Thompson WW. 2004. MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines 3: 19-22. (Pubitemid 38196952)
22. Dinarello CA. 2010. IL-1: discoveries, controversies and future directions. Eur J Immunol. 40:599-606.
23. Edmonds JL, et al. 2002. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol Head Neck Surg 128: 355-362.
24. Elliott HR, et al. 2008. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254-260.
25. Fatemi SH, et al. 2001. Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum. Neuroreport 12:929-933.
26. Filipek PA, et al. 2004. Relative carnitine deficiency in autism. J Autism Dev Disord 34: 615-623.
27. Filipek PA, et al. 2003. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 53:801-804.
28. Filano JJ, et al. 2002. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 17:435-439.
29. Fombonne E. 2003. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 33:365-382. (Pubitemid 37127933)
30. Fombonne E, Chakrabarti S. 2001. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 108:E58.
31. Fombonne E, et al. 2006. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 118:e139-50.
32. Gamero AM, et al. 2006. Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms. Cell Signal 18:1299-308.
33. Garcia-Ruiz I, et al. 2006. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44:581-591.
34. Giordano C, et al. 2008. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 173:1120-1128.
35. Glessner JT, et al. 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569-573.
36. Graf WD, et al. 2000. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 15: 357-361.
37. Haas RH. et al. 2007. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120:1326-1333.
38. Haas RH, et al. 2008. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94:16-37.
39. Haas RH, et al. 1996. Neurologic abnormalities in infantile autism. J Child Neurol 11:84-92.
40. Halsey NA, Hyman SL. 2001. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, IL, 12-13 June, 2009. Pediatrics 107:E84.
41. Hansen RL, et al. 2008. Regression in autism: prevalence and associated factors in the CHARGE Study. Ambul Pediatr 8:25-31.
42. Hashem RM, et al. 2008. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive bio-marker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. Eur J Gastroenterol Hepatol 20:995-1001.
43. Hirano M, et al. 1994. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721-727.
44. Honey K. 2008. Attention focuses on autism. J Clin Invest 118:1586-1587.
45. Hornig M, et al. 2008. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One 3:1-8.
46. Hoffman GF, et al. 2001. Handbook of inherited metabolic diseases, New York; Lippincott Williams and Wilkins.
47. James SJ, et al. 2009. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23:2374-2383.
48. Johnson CP, Myers SM. 2007. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183-1215.
49. Jyonouchi H, et al. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120:170-179. (Pubitemid 33016737)
50. Kakinuma H, Sato H. 2008. Copy-number variations associated with autism spectrum disorder. Pharmacogenomics 9:1143-1154.
51. Kurita H. 1996. Specificity and developmental consequences of speech loss in children with pervasive developmental disorders. Psychiatry Clin Neurosci 50:181-184.
52. Lancet. 2010. Retraction - ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445.
53. Laszlo A, et al. 1994. Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta 229:205-207. (Pubitemid 24269187)
54. Lord C, et al. 2004. Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry 45:936-955.
55. Marshall CR, et al., 2008. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477-488.
56. Meisinger C, et al. 2008. The mitochondrial proteome: from inventory to function. Cell 134:22-24.
57. Mouridsen SE, et al. 2009. A longitudinal study of gastrointestinal diseases in individuals diagnosed with infantile autism as children. Child Care Health Dev 36:437-443.
58. Neutzner A, et al. 2008. Role of the ubiquitin conjugation system in the maintenance of mitochondrial homeostasis. Ann NY Acad Sci 1147:242-253.
59. Nikolov RN, et al. 2009. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 39:405-413.
60. NINDS. 2008. Mitochondrial encephalomyopathies: potential relationships to Autism? Indianapolis, IN: Workshop. Available at: http://www.ninds.nih.gov/ news-and-events/ proceedings/20090629-mitochondrial.htm. Accessed June 29, 2008.
61. Oliveira G, et al. 2007. Epidemiology of autism spectrum disorder in Portugal: prevalence, clinical characterization, and medical conditions. Dev Med Child Neurol 49:726-733.
62. Oliveira G, et al. 2005. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47: 185-189.
63. Palmieri L, et al. 2010. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 15:38-52.
64. Poling JS, et al. 2006. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 21:170-172.
65. Pons R, et al. 2004. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 144:81-85. (Pubitemid 38091426)
66. Procter M, et al. 2006. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification. Clin Chem 52: 1276-1283.
67. Psarra AM, et al. 2006. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Ann NY Acad Sci 1088:12-22.
68. Qian L, et al. 2004. Mitochondrial mechanism of heat stress-induced injury in rat cardiomyocyte. Cell Stress Chaperones 9:281-293.
69. Ricquier D, Bouillaud F. 2000. The uncoupling protein homologues: UCP1. UCP2, UCP3, StUCP and AtUCP. Biochem J 345:161-179.
70. Roohi J, et al. 2009. Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet 46:176-182.
71. Schaefer AM, et al. 2008. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35-39.
72. Sebat J, et al. 2007. Strong association of de novo copy number mutations with autism. Science 316:445-449.
73. Sheikh AM, et al. 2010. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 165:363-370.
74. Shen Y, et al. 2010. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125:e727-e735.
75. Shoffner J, et al. 2010. Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol 25:429-434.
76. Skaper SD. 2007. The brain as a target for inflammatory processes and neuroprotective strategies. Ann NY Acad Sci 1122:23-34.
77. Smith SE. et al. 2007. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695-10702.
78. Sugarman SD. 2007. Cases in vaccine court-legal battles over vaccines and autism. N Engl J Med 357:1275-1277.
79. Sweeten TL, et al. 2004. High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 55: 434-437.
80. Szatmari P. et al. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319-328.
81. Tsao CY, Mendell JR. 2007. Autistic disorder in 2 children with mitochondrial disorders. J Child Neurol. 22:1121-1123. (Pubitemid 47412687)
82. Valicenti-McDermott M, et al. 2006. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 27:S128-S136.
83. Vargas DL, et al. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67-81. (Pubitemid 40053317)
84. Verny C, et al. 2008. Mitochondrial DNA A3243G mutation involved in familial diabetes, chronic intestinal pseudo-obstruction and recurrent pancreatitis. Diabetes Metab 34:620-626.
85. Vives-Bauza C, et al. 2010. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 107: 378-383.
86. Waxman AB, Kolliputi N. 2009. IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am J Respir Cell Mol Biol 41:385-396.
87. Weissman JR. et al. 2008. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 3:e3815.
88. Williams JG, et al. 2006. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child 91:8-15.
89. Wolf NI, Smeitink JA. 2002. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 59: 1402-1405.
90. Zimmerman RK, et al. 2005. Vaccine criticism on the World Wide Web. J Med Internet Res 7:e17.